These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 16611010)

  • 21. Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons.
    Mamada N; Tanokashira D; Hosaka A; Kametani F; Tamaoka A; Araki W
    Mol Brain; 2015 Nov; 8(1):73. PubMed ID: 26552445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.
    Sambamurti K; Suram A; Venugopal C; Prakasam A; Zhou Y; Lahiri DK; Greig NH
    Curr Alzheimer Res; 2006 Feb; 3(1):81-90. PubMed ID: 16472208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
    Kasparová J; Dolezal V
    Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid toxicity in Alzheimer's disease.
    Reiss AB; Arain HA; Stecker MM; Siegart NM; Kasselman LJ
    Rev Neurosci; 2018 Aug; 29(6):613-627. PubMed ID: 29447116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
    Sciaccaluga M; Megaro A; Bellomo G; Ruffolo G; Romoli M; Palma E; Costa C
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease.
    Maloney MT; Minamide LS; Kinley AW; Boyle JA; Bamburg JR
    J Neurosci; 2005 Dec; 25(49):11313-21. PubMed ID: 16339026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing the spread of Alzheimer's disease neuropathology: a role for calcilytics?
    Chiarini A; Gardenal E; Whitfield JF; Chakravarthy B; Armato U; Dal Pra I
    Curr Pharm Biotechnol; 2015; 16(8):696-706. PubMed ID: 25941885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta and APP as biomarkers for Alzheimer's disease.
    Zetterberg H; Blennow K; Hanse E
    Exp Gerontol; 2010 Jan; 45(1):23-9. PubMed ID: 19698775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
    Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
    Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.